C
CLDI
Calidi Biotherapeutics Inc
0.8370
-0.0331-3.80%After Hours: 0.8400 +0.0030 +0.36%18:04 10/16 EDT
OPEN/PREV CLOSE0.8897/0.8701
TODAY RANGE0.7900-0.8897
VOL35.20K
MARKET CAP3.08M
52 WEEK RANGE0.7900-27.84
AVG VOL (3M)252.06K
% TURNOVER0.93%
TURNOVER--
P/E (TTM)-0.0085
% RANGE10.13%
EPS(TTM)-98.2600
P/E(FORWARD)-0.0070
P/B0.5564
BVPS1.504
DIVIDEND--
P/S1,150.00
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.06M
SHARES OUTSTANDING3.68M
NEXT EARNINGS--
FREE FLOAT3.65M
LOT SIZE1
EX-DATE07/31/2026
News
Press Releases
Financial Reports
Profile
Benzinga·10/06 21:05
12 Health Care Stocks Moving In Tuesday's After-Market Session
TipRanks·09/25 22:53
Calidi Biotherapeutics Addresses NYSE American Compliance Notice
Seeking Alpha·09/25 21:12
Calidi Biotherapeutics gets NYSE compliance warning but stock surprises
Benzinga·09/25 21:03
Calidi Biotherapeutics Receives NYSE American Non-Compliance Notice
TipRanks·09/22 21:29
Calidi Biotherapeutics Announces Registered Direct Stock Offering
TipRanks·09/17 13:35
Calidi prices 1.025M shares at $1.17 in registered direct offering
Benzinga·08/28 12:06
12 Health Care Stocks Moving In Friday's Pre-Market Session
TipRanks·08/13 21:31
Calidi Biotherapeutics Reports Quarterly Results and Pipeline Progress
Seeking Alpha·08/13 21:07
Calidi Biotherapeutics GAAP EPS of -$2.94
Benzinga·08/13 20:41
Calidi Biotherapeutics Q2 EPS $(2.94) Down From $(1.99) YoY
Dow Jones·08/13 20:31
*Calidi Biotherapeutics 1Q Loss/Shr $2.94 >CLDI
Dow Jones·08/13 20:30
Press Release: Calidi Biotherapeutics Reports -2-
TipRanks·07/31 21:33
Calidi Biotherapeutics Implements Reverse Stock Split on NYSE